Increased Levels of sCD30 Have No Impact on the Incidence of Early ABMR and Long-Term Outcome in Intermediate-Risk Renal Transplant Patients With Preformed DSA

Background: It is still incompletely understood why some patients with preformed donor-specific anti-HLA antibodies (DSA) have reduced kidney allograft survival secondary to antibody-mediated rejection (ABMR), whereas many DSA-positive patients have favorable long-term outcomes. Elevated levels of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Drasch, Thomas, Bach, Christian, Luber, Markus, Spriewald, Bernd, Utpatel, Kirsten, Büttner-Herold, Maike, Banas, Bernhard, Zecher, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606593/
https://www.ncbi.nlm.nih.gov/pubmed/34820407
http://dx.doi.org/10.3389/fmed.2021.778864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606593/
https://www.ncbi.nlm.nih.gov/pubmed/34820407
http://dx.doi.org/10.3389/fmed.2021.778864

Ejemplares similares